Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -159.35% | -154.93% | -100.42% | -45.64% | 30.16% |
| Total Depreciation and Amortization | -6.74% | -40.03% | -30.61% | -16.98% | 3.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.89% | -259.60% | -379.27% | -2,088.24% | -484.08% |
| Change in Net Operating Assets | -65.53% | 497.11% | 187.00% | 219.93% | 198.10% |
| Cash from Operations | -129.97% | -118.27% | -35.21% | -3.04% | 219.16% |
| Capital Expenditure | -2,087.67% | 94.76% | 103.46% | 100.00% | 62.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.48% | 150.24% | 24.04% | 90.51% | -- |
| Cash from Investing | 67.74% | 150.14% | 24.38% | 90.54% | -21,756.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 67.44% | 66.67% | 61.69% | -55.22% | 58.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.09% | 0.09% | 0.09% | 0.02% | 49.99% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.40% | 1.45% | 1.49% | -0.82% | 50.17% |
| Foreign Exchange rate Adjustments | -125.69% | -169.35% | -177.58% | -118.57% | 236.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.42% | 132.11% | 9.48% | 90.01% | -33.64% |
